Insider Transactions in Q4 2023 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2023
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
10,411
-1.73%
|
$0
$0.38 P/Share
|
|
Nov 25
2023
|
David Mark Mc Clung EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,925
-0.9%
|
$0
$0.38 P/Share
|
|
Nov 25
2023
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,329
-1.04%
|
$0
$0.38 P/Share
|
|
Nov 25
2023
|
Amy Pooler VP, HEAD OF RESEARCH |
SELL
Payment of exercise price or tax liability
|
Direct |
490
-0.95%
|
$0
$0.38 P/Share
|
|
Nov 25
2023
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,462
-1.04%
|
$0
$0.38 P/Share
|
|
Nov 25
2023
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,329
-1.0%
|
$0
$0.38 P/Share
|
|
Nov 25
2023
|
Jason D. Fontenot SVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,030
-0.75%
|
$0
$0.38 P/Share
|